Skip to main content
Premium Trial:

Request an Annual Quote

RBM to Use $849K from NIGMS to Develop Dx for Neonatal Sepsis

NEW YORK (GenomeWeb News) - Rules Based Medicine has won an $849,000 fast-track grant from the National Institute for General Medical Sciences to develop a test through a collaboration with the University of New Mexico in Albuquerque that would diagnose neonatal sepsis.
 
The company said that it will perform all of the testing and statistical analysis on samples provided by the University of New Mexico’s Neonatal Intensive Care ward. Specifically, RBM will use its HumanMAP platform to characterize and validate a pattern of biomarkers that can detect early signs of infection in newborns.
 
“The ability to routinely monitor serum biomarkers for the earliest signs of infection could have a significant impact on the survival rates of the newborns most at risk,” said UNM Professor of Medicine Clifford Lyons.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.